1. Home
  2. CFBK vs CNTN Comparison

CFBK vs CNTN Comparison

Compare CFBK & CNTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CF Bankshares Inc.

CFBK

CF Bankshares Inc.

HOLD

Current Price

$28.62

Market Cap

178.1M

Sector

Finance

ML Signal

HOLD

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$3.12

Market Cap

185.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CFBK
CNTN
Founded
1892
2017
Country
United States
United States
Employees
N/A
12
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
178.1M
185.3M
IPO Year
2005
2022

Fundamental Metrics

Financial Performance
Metric
CFBK
CNTN
Price
$28.62
$3.12
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$31.50
N/A
AVG Volume (30 Days)
20.9K
461.0K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
1.23%
N/A
EPS Growth
30.58
N/A
EPS
0.77
N/A
Revenue
N/A
N/A
Revenue This Year
$31.99
N/A
Revenue Next Year
$9.09
N/A
P/E Ratio
$37.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.10
$2.89
52 Week High
$34.34
$5.27

Technical Indicators

Market Signals
Indicator
CFBK
CNTN
Relative Strength Index (RSI) 58.82 42.96
Support Level $28.40 $3.04
Resistance Level $30.25 $3.82
Average True Range (ATR) 0.64 0.27
MACD 0.22 -0.01
Stochastic Oscillator 83.09 10.39

Price Performance

Historical Comparison
CFBK
CNTN

About CFBK CF Bankshares Inc.

CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans, and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

Share on Social Networks: